Intellia

Intellia
Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Gene Editing
CRISPR Technology
Cell Engineering
Bioinformatics
Drug Development
Intellia 채용공고
채용공고 0개
현재 채용 중인 채용공고가 없습니다
제품 및 서비스
CR
CRISPR/Cas9 Gene Editing Platform
Gene Editing Technology
NT
NTLA-2001
Gene Editing Therapy
NT
NTLA-3001
Gene Editing Therapy
EX
Ex Vivo Cell Engineering
Cell Engineering Service
NT
NTLA-2002
Gene Editing Therapy
NE
Neurological Disease Programs
Gene Editing Therapy
PR
Primary Hyperoxaluria Program
Gene Editing Therapy
MO
Modular CRISPR Platform
Platform Technology
AS
ASGR1 Program
Gene Editing Therapy
IN
In Vivo Gene Editing Services
Gene Editing Service
LI
Lipid Nanoparticle Delivery System
Drug Delivery Technology

NTLA-5001
Cell Therapy
IM
Immunology Pipeline
Therapeutic Pipeline

NTLA-2003
Gene Editing Therapy

Asgard Platform
Platform Technology
LI
Lipid Nanoparticle Platform
Technology Platform
ON
Oncology Cell Therapies
Cell Therapy

Engineered Cell Medicines
Cell Therapy
CR
CRISPR Platform Technology
Technology Platform
유사 기업

Merck
Multinational pharmaceutical company.
Rahway, New Jersey
10,001+명
상장
기업가치 $208B
848개 채용공고

Insulet
Multinational healthcare company.
Bedford, Massachusetts, United States
501-1,000명
상장
기업가치 $2.1B

Mammoth Biosciences
Biotechnology company.
San Francisco, California, United States
51-200명
비상장
기업가치 $800M
2개 채용공고

Pfizer
Breakthroughs that change patients' lives.
New York City, New York
10,001+명
상장
기업가치 $280B
499개 채용공고

Bluebird Bio
Develops gene therapies for severe genetic disorders.
Somerville, Massachusetts
201-500명
상장
기업가치 $350M
최근 소식
All
X
News
HN
YouTube
Intellia Files BLA After Lonvo-z Meets Phase 3 Endpoints - CRISPR Medicine News
CRISPR Medicine News
News
·
1개월 전
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
·
1개월 전
·
1
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA) - TipRanks.com
Bull signal if I ever saw one
·
1개월 전
·
89
·
34
Why Intellia Therapeutics (NTLA) Is Down 13.8% After Positive Phase 3 HAE Gene-Editing Results And FDA Filing - simplywall.st
simplywall.st
News
·
1개월 전
Intellia races in vivo CRISPR therapy to FDA after phase 3 data paint ‘compelling’ picture
·
1개월 전
·
28
더 보기 (15개 남음)
전체 조회수
0
전체 지원 클릭
0
전체 Mock Apply
0
전체 스크랩
0
리뷰
2.7
2개 리뷰
워라밸
3.0
보상
3.0
문화
2.0
커리어
2.5
경영진
1.5
25%
지인 추천률
장점
Potential for meaningful medical impact
Working on innovative treatments
Opportunity to help patients with rare diseases
단점
Poor management decisions
Unfair layoff practices
Favoritism in promotions
연봉 정보
47개 데이터
Mid/L4
Mid/L4
1개 리포트
$214,500
총 연봉
기본급
$165,000
주식
-
$214,500
$214,500
면접 후기
후기 1개
난이도
3.0
/ 5
소요 기간
2-5w
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Offer
연락처 및 위치